Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANRO is expected to report earnings to rise 26.15% to -81 cents per share on November 11

Alto Neuroscience ANRO Stock Earnings Reports

Q3'26

Est.

$-0.82

Q2'26

Beat

by $0.10

Q1'26

Missed

by $0.12

Q4'25

Beat

by $0.20

Q3'25

Beat

by $0.12

The last earnings report on August 12 showed earnings per share of -64 cents, beating the estimate of -75 cents. With 70.17K shares outstanding, the current market capitalization sits at 1.05B.

View a ticker or compare two or three

ANRO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ANRO